No Detail Found!

Secretome of Human MSC Gel Improves DFU Healing through NF-xB p50 and CD163 mRNA Expression

Author(s)
Nur Anna Chalimah Sadyah Program of Medical and Health Science, Universitas Diponegoro, Semarang, Indonesia; Department of Internal Medicine, Sultan Agung Islamic Hospital, Semarang, Indonesia; Department of Internal Medicine, Faculty of Medicine, Universitas Islam Sultan Agung, Semarang, Indonesia
Heri-Nugroho Department of Internal Medicine, Faculty of Medicine, Diponegoro University, Semarang, Indonesia
Agung Putra Stem Cell and Cancer Research, Semarang, Indonesia; Department of Postgraduate Biomedical Science, Faculty of Medicine, Universitas Islam Sultan Agung, Semarang, Indonesia
Ignatius Riwanto Department of Surgery, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia
Abstract
Background and Objective: Diabetic foot ulcers (DFUs) remain a critical clinical problem and stem cell-derived secretome reared under hypoxic conditions has been shown to play a significant role in tissue repair viaimmunomodulation. This study aimed to evaluate the secretome of human mesenchymal stem cell gel (SH-MSC gel) in DFU patients with grades 2 and 3 through reduced wound volume and modulation of CD163 and NF-xB p50 mRNA expression. Materiaalnsd Methods: A prospective, randomized controlled clinical trial involved 16 DFU patients with grades 2 and 3. Participants received either a placebo gel or anintervention gel containing secretome from Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSCs) cultured under hypoxic conditions. All patients received standard wound care. Primary outcomes included changes in wound volume and expression levels of CD163 and NF-«B p50 mRNA in wound tissue, assessed using quantitative PCR. The Shapiro-Witleskt assessed normality and for normally distributed data, paired t-tests (within-group) and unpaired t-tests (between-grouwepr)e used. One-way ANOVA compared means across groups, while the Kruskal-Wallistestfollowed by post hoc analysis was employed for non-parametric data (p<0.05). Statistical analysis was performed using GraphPad Prism 10. Results: Baseline characteristics of participants did not show significant differences between the groups. Treatment with SH-MSC gel significantly enhanced wound healing compared to the placebo group, evidenced by a marked reduction in wound volume after 7 days (95% C1(0.467 to 1.18), p<0.001). The CD163 mRNA expression significantly increased in the SH-MSC gel group post-treatm(e9n5%t Cl (-2.20to-1.11), p<0.001), while NF-«B p50 mRNA expression significantly decreased (95% Cl (0.349 to 0.688), p<0.001). Conclusion: The clinical trial results suggested that SH-MSC gel effectively improves wound healing in DFUs. Further research is warranted to explore additional inflammatory markers to better understand DFU treatment.
Publication Details
Page(s) 151-161
Published Journal: Pakistan Journal of Biological Sciences, Volume: 28, Issue: 1, Year: 2025

Request the full text from PASTIC

Keywords
wound healing, diabetic foot ulcers, stem cells, CD163 antigen, NF-x8 p30
References
Sanjeeviraj S,Subburaj A.,Jalan M.,Joseph A.G. .2023 .A cohort study on the outcome of diabetic foot ulcers. Cureus, 15 : .
da Ros,R Ros,Assaloni R.,Michelli A.,Brunato B.,Meloni M.,Miranda C. .2024 .Burden ofinfected diabetic foot ulcers on hospital admissions and costs in a third-level center. Diabetology, 5 : 141-150.
Yazdanpanah L.,Shahbazian H.,Hesam S.,Ahmadi B.,Zamani A.M. .2024 .Two-year incidence and risk factors of diabetic foot ulcer: Second phase report of Ahvaz diabetic foot cohort (ADFC) study. BMC Endocr. Disord., 24 : .
. .. , : 512902.
Mieczkowski M.,Mrozikiewicz-Rakowska B.,Kowara M.,Kleibert M.,Czupryniak L. .2022 .The problem of wound healing in diabetes-from molecular pathways to the design of an animal model. Int. J. Mol. Sci, 23 : .
. .. , : .
Bardill JR,Laughter M.R.,Stager M.,Krebs M.D.,Zgheib C. .2022 .Topical gel-based biomaterials for the treatment of diabetic foot ulcers. Acta Biomater., 138 : 73-91.
Tianwattanatada S.,Namviriyachote N.,Chinaroonchai K.,Owattanapanich N.,Muangman P. .2021 .. , : .
MJ ,R ,Huang X.,Li D.,Ding J.,Liu B.,Chen X.,Guo Q.Y.,Jin X.,Chen X.,Ye X. Shen etal .2024 .B in biology and targeted therapy: New insaind tgranhslattiosnal implications. Signal Transduct. Target Ther, 9 : 541392-757.
. Shin J.J,J. Park H.S.,Shin K.,Suk W.H.,Lee W.H. .2024 .Roles of IncRNAs in NF-xB-mediated macrophage inflammation and their implications in the pathogenesis of human diseases. Int. J. Mol. Sci, 25 : .
. Mahmoudvand G.,Razavi Z.S.,Mahjoor M.,Afkhami H. .2023 .Mesenchymal stem cell therapy for non-healing diabetic foot ulcer infectioNnew: insight. , 1158484 : .
AB ,Moy L.,Moy R.,Tung R. .2019 .Circadian rhythm and the skin: A review of the literature. J. Clin. Aesthetic Dermatol, 12 : 42-45.
Wang .,B .,Pang M.,Song Y.,Wang H. .2023 .Human fetal mesenchymal stem cells secretome promotes scarless diabetic wound healing through heat-shock protein family. Bioeng. Transl. Med, 8 : 10354.
HF ,Elsaghir A,SA A .2036 .Mesenchymal stem cell therapy in diabetic foot ulcer: An updated comprehensive review. Health Sci. Rep, 7 : .
. Farabi B,Roster K.,Hirani R.,Tepper K.,Safai B. .2024 .The efficacy of stem cells in wound healA isysntegmat:ic review. Int. J. Mol. Sci,, 25 : .
Li .,X .,Zhang D.,Yu Y.,Wang L.,Zhao M. .2024 .Umbilical cord-derived mesenchymal stem cell secretome promotes skin regeneration and rejuvenation: From mechanism to therapeutics. Cell Proliferation, 57 : .
. Holthaus M.,Santhakumar N.,Wahlers T.,PaunelGorgult A. .2022 .The secretome of preconditioned mesenchymal stem cells drives polarization and reprogramming of M2a macrophages toward an IL-10- producing phenotype. Int. J. Mol. Sci., 23 : .
Labrie C.,Etzerodt A.,Charoentong P.,Thans J.J.C.van Stigt,S.H. van der Burg J.J.C.van Stigt .2023 .Invasive margin tissue-resident macrophages of high CD163 expression impede responses to T cell-based immunotherapy. J. ImmunoTher. Cancer, 11 : .
Lentilhas-Graga J,Santos D.J.,Afonso J.,A. J. .2024 .The secretome of macrophages has a differential impact on spinal cord injury recovery according to the polarization protocol. Front. Immunol,, 1354479 : .
Chen L,Song J.,Chen K.,Ni W. .2023 .CD163 protein inhibits lipopolysaccharide-induced macrophage transformation from M2 to M1 involved in disruption of the TWEAK-Fn14 interaction. Heliyon, 10 : .
Dyachkova U,Basalova N.,Efimenko A.,Grigorieva O. .2023 .-macrophage-induced chronic inflammation promotes reversible mesenchymal stromal cell senescence and reduces their anti-fibrotic properties. Int. J. Mol. Sci, 24 : .
Y ,Zhao J.,Zhang L.,Li Z.,Lei S. .2022 .Effectiveness and safety of stem cell therapy for diabetic foot: A meta-analysis update. Stem Cell Res. Ther,, 13 : 513287.
0

Citations

0

Downloads

38

Views